Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • #JHM Chat
  • Industry Content
    • Patient Monitoring with Tech

Circulatory

  • News

    COVID-19: Thromboembolic events high despite prophylaxis

    October 27, 2020

    “Standard prophylaxis as recommended in the guidelines is a low dose of low-molecular-weight heparin once daily, but these results suggest [patients] probably need higher doses.”

  • News

    ‘Cautious’ DOAC underdosing in AFib may push mortality higher

    September 21, 2020

    Risk-averse clinicians might be doing more harm than good by prescribing direct oral anticoagulants at lower-than-recommended dosages in hope of avoiding bleeding complications, suggests a study.

  • 1
    News

    HOME-PE trial clarifies which pulmonary embolism patients to treat at home

    September 1, 2020

    “Who’s happy with the HOME-PE trial? I think everybody.” – Dr. Stavros V. Konstantinides

  • 1
    News

    ESC’s revised NSTE-ACS guidelines embrace hsT, personalized anti-ischemia treatments

    August 31, 2020

    The first guideline update in 5 years for non ST-elevation ACS stresses high sensitivity troponin for diagnosis and tailored antiplatelet treatments.

  • 1
    News

    Continued extension of time for thrombolysis in stroke

    August 12, 2020

    Is thrombolysis beneficial between 4.5 and 9 hours after onset of stroke in patients with hypoperfused but salvageable regions of brain detected on automated perfusion imaging?

  • News

    HM20 Virtual Product Theater: Aug. 12

    August 6, 2020

    Hear from Dr. Michael Oleksyk, clinical assistant professor at Florida State University, Pensacola, to learn more about venous thromboembolism prophylaxis, as well as treatment options for patients with deep vein thrombosis and/or pulmonary embolism.

  • 1
    News

    Patent foramen ovale linked with increased risk of ischemic stroke in PE

    August 6, 2020

    Is patent foramen ovale (PFO) associated with increased risk of ischemic stroke in patients diagnosed with acute pulmonary embolism (PE)?

  • 1
    News

    No rise in major hemorrhagic events with antiplatelet therapy after ICH

    August 3, 2020

    Does the risk of increased recurrent intracerebral hemorrhage (ICH) exceed the benefits of decreased vaso-occlusive events for patients resuming antiplatelet therapy following an ICH?

  • 1
    Opinion

    Hematologic manifestations of COVID-19

    July 29, 2020

    Dr. Alan P. Lyss examines a review on extrapulmonary manifestations of COVID-19, focusing in on hematologic effects.

  • News

    Low-dose prasugrel preserves efficacy but lowers bleeding in elderly

    July 23, 2020

    In an ISAR-REACT 5 substudy of elderly ACS patients, low-dose prasugrel was favored over ticagrelor.

Previous1 … 5 6 7 8 9 … 25Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
fa-facebookfa-linkedinfa-instagramfa-youtube-playfa-commentfa-envelopefa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences